ITP BLOCK FOR MINOR BREAST CANCER SURGERY

Phase 1

• Conditions: Breast cancer; MedDRA version: 20.0Level: PTClassification code: 10006187Term: Breast cancer Class: 100000004864; Therapeutic area: Diseases [C] - Neoplasms [C04]

• Registration Number: CTIS2022-501312-34-00
• Lead Sponsor: Zealand University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-15
• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Patients scheduled for day case elective unilateral minor breast cancer (including DCIS) surgery, Age = 18 years at the date of inclusion, American Associations of Anaesthesiologist (ASA) class I-III, Have received thorough information, orally and in written form, and signed the Informed Consent” form on participation in the study., Weight > 52,5 kilograms (chosen due to the maximum single dose of Ropivacaine (3mg/kg))

Exclusion Criteria

Substantial co-morbidity: American Associations of Anaesthesiologist (ASA) class > III, Any systemic muscular or neuromuscular disease, Any use of vasodilatory substance (investigators decision), Local infection at the site of injection or systemic infection, Difficult sonoanatomical visualisation of the target area (SCTL, ITTC etc.) necessary for the block execution, Severe hypovolemia, Pregnant or breastfeeding, Inability to speak and understand Danish, Inability to cooperate, Allergy to study drugs, Daily intake of analgesics (investigators decision), Alcohol and/or drug overuse (investigators decision), Previous thoracic trauma or thoracic surgery, Previous/current piercing of the nipple of any kind on blockade side, Tattoos on the thorax (according to the investigators decision)

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified